Skip to main content
Microbiological Reviews logoLink to Microbiological Reviews
. 1982 Jun;46(2):162–190. doi: 10.1128/mr.46.2.162-190.1982

The meningococcus and mechanisms of pathogenicity.

I W DeVoe
PMCID: PMC281537  PMID: 6126800

Full text

PDF
162

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYCOCK W. L., MUELLER J. H. Meningococcus carrier rates and meningitis incidence. Bacteriol Rev. 1950 Jun;14(2):115–160. doi: 10.1128/br.14.2.115-160.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams G. A., Kates M., Shaw D. H., Yaguchi M. Studies on the chemical constitution of cell-wall lipopolysaccharides from Neisseria perflava. Can J Biochem. 1968 Oct;46(10):1175–1184. doi: 10.1139/o68-176. [DOI] [PubMed] [Google Scholar]
  3. Adams G. A., Tornabene T. G., Yaguchi M. Cell wall lipopolysaccharides from Neisseria catarrhalis. Can J Microbiol. 1969 Apr;15(4):365–374. doi: 10.1139/m69-067. [DOI] [PubMed] [Google Scholar]
  4. Adler L., Brundell J., Falkbring S. O., Nyman P. O. Carbonic anhydrase from Neisseria sicca, strain 6021. I. Bacterial growth and purification of the enzyme. Biochim Biophys Acta. 1972 Sep 19;284(1):298–310. doi: 10.1016/0005-2744(72)90068-x. [DOI] [PubMed] [Google Scholar]
  5. Apicella M. A., Breen J. F., Gagliardi N. C. Degradation of the polysaccharide component of gonococcal lipopolysaccharide by gonococcal and meningococcal sonic extracts. Infect Immun. 1978 Apr;20(1):228–234. doi: 10.1128/iai.20.1.228-234.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Apicella M. A. Lipopolysaccharide-derived serotype polysaccharides from Neisseria meningitidis group B. J Infect Dis. 1979 Jul;140(1):62–72. doi: 10.1093/infdis/140.1.62. [DOI] [PubMed] [Google Scholar]
  7. Apicella M. A., Robinson J. A. Physicochemical Properties of Neisseria meningitidis Group C and Y Polysaccharide Antigens. Infect Immun. 1970 Oct;2(4):392–397. doi: 10.1128/iai.2.4.392-397.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Apicella M. A., Robinson J. A. Physicochemical properties of Neisseria meningitidis group X polysaccharide antigen. Infect Immun. 1972 Nov;6(5):773–778. doi: 10.1128/iai.6.5.773-778.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Archibald F. S., DeVoe I. W. Iron acquisition by Neisseria meningitidis in vitro. Infect Immun. 1980 Feb;27(2):322–334. doi: 10.1128/iai.27.2.322-334.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Archibald F. S., DeVoe I. W. Iron in Neisseria meningitidis: minimum requirements, effects of limitation, and characteristics of uptake. J Bacteriol. 1978 Oct;136(1):35–48. doi: 10.1128/jb.136.1.35-48.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Archibald F. S., Simonson C., DeVoe I. W. Comparison of iron binding and uptake from FeCl3 and Fe-citrated by Neisseria meningitidis. Can J Microbiol. 1981 Oct;27(10):1066–1070. doi: 10.1139/m81-166. [DOI] [PubMed] [Google Scholar]
  12. Artenstein M. S., Gold R., Zimmerly J. G., Wyle F. A., Schneider H., Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970 Feb 19;282(8):417–420. doi: 10.1056/NEJM197002192820803. [DOI] [PubMed] [Google Scholar]
  13. Artenstein M. S., Miller W. S., Lamson T. H., Brandt B. L. Large-volume air sampling for Meningococci and Adenoviruses. Am J Epidemiol. 1968 May;87(3):567–577. doi: 10.1093/oxfordjournals.aje.a120847. [DOI] [PubMed] [Google Scholar]
  14. Artenstein M. S., Winter P. E., Gold R., Smith C. D. Immunoprophylaxis of meningococcal infection. Mil Med. 1974 Feb;139(2):91–95. [PubMed] [Google Scholar]
  15. BANKS H. S. Meningococcosis; a protean disease. Lancet. 1948 Oct 30;2(6531):677–681. [PubMed] [Google Scholar]
  16. BLACKLOW R. S., WARREN L. Biosynthesis of sialic acids by Neisseria meningitidis. J Biol Chem. 1962 Nov;237:3520–3526. [PubMed] [Google Scholar]
  17. BRANHAM S. E. Milestones in the history of the meningococcus. Can J Microbiol. 1956 May;2(3):175–188. doi: 10.1139/m56-023. [DOI] [PubMed] [Google Scholar]
  18. Bastos C. de O., Taunay A. de E., Galvão P. A., Tiriba A. da C., Saraiva P. A., Castro I. de O., Lomar A. V. Meningites. Consideraçes gerais sobre 15.067 casos internados no Hospital "Emílio Ribas" durante o qüindênio 1958-1972. Ocorrência, etiologia e letalidade. AMB Rev Assoc Med Bras. 1973 Nov;19(11):451–456. [PubMed] [Google Scholar]
  19. Bell W. E., Silber D. L. Meningococcal meningitis: past and present concepts. Mil Med. 1971 Jul;136(7):601–611. [PubMed] [Google Scholar]
  20. Bhattacharjee A. K., Jennings H. J., Kenny C. P., Martin A., Smith I. C. Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO1. Can J Biochem. 1976 Jan;54(1):1–8. doi: 10.1139/o76-001. [DOI] [PubMed] [Google Scholar]
  21. Bhattacharjee A. K., Jennings H. J., Kenny C. P., Martin A., Smith I. C. Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance. J Biol Chem. 1975 Mar 10;250(5):1926–1932. [PubMed] [Google Scholar]
  22. Bhattacharjee A. K., Jennings H. J., Kenny C. P. Structural elucidation of the 3-deoxy-D-manno-octulosonic acid containing meningococcal 29-e capsular polysaccharide antigen using carbon-13 nuclear magnetic resonance. Biochemistry. 1978 Feb 21;17(4):645–651. doi: 10.1021/bi00597a013. [DOI] [PubMed] [Google Scholar]
  23. Bovre K., Holten E., Vik-Mo H., Brondbo A., Bratlid D., Bjark P., Moe P. J. Neisseria meningitidis infections in Northern Norway: an epidemic in 1974-1975 due mainly to group B organisms. J Infect Dis. 1977 Apr;135(4):669–672. doi: 10.1093/infdis/135.4.669. [DOI] [PubMed] [Google Scholar]
  24. Brandt B. L., Artenstein M. S. Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide. J Infect Dis. 1975 May;131 (Suppl):S69–S72. doi: 10.1093/infdis/131.supplement.s69. [DOI] [PubMed] [Google Scholar]
  25. Brandt B. L., Artenstein M. S., Smith C. D. Antibody responses to meningococcal polysaccharide vaccines. Infect Immun. 1973 Oct;8(4):590–596. doi: 10.1128/iai.8.4.590-596.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Brener D., DeVoe I. W., Holbein B. E. Increased virulence of Neisseria meningitidis after in vitro iron-limited growth at low pH. Infect Immun. 1981 Jul;33(1):59–66. doi: 10.1128/iai.33.1.59-66.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Broud D. D., Griffiss J. M., Baker C. J. Heterogenity of serotypes of Neisseria meningitidis that cause endemic disease. J Infect Dis. 1979 Oct;140(4):465–470. doi: 10.1093/infdis/140.4.465. [DOI] [PubMed] [Google Scholar]
  28. Brundell J., Falkbring S. O., Nyman P. O. Carbonic anhydrase from Neisseria sicca, strain 6021. II. Properties of the purified enzyme. Biochim Biophys Acta. 1972 Sep 19;284(1):311–323. doi: 10.1016/0005-2744(72)90069-1. [DOI] [PubMed] [Google Scholar]
  29. Buchanan T. M., Pearce W. A. Pili as a mediator of the attachment of gonococci to human erythrocytes. Infect Immun. 1976 May;13(5):1483–1489. doi: 10.1128/iai.13.5.1483-1489.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Buddingh G. J., Polk A. D. A STUDY OF PASSIVE IMMUNITY TO MENINGOCOCCUS INFECTION IN THE CHICK EMBRYO. J Exp Med. 1939 Oct 31;70(5):511–520. doi: 10.1084/jem.70.5.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Buddingh G. J., Polk A. D. EXPERIMENTAL MENINGOCOCCUS INFECTION OF THE CHICK EMBRYO. J Exp Med. 1939 Oct 31;70(5):485–498. doi: 10.1084/jem.70.5.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Buddingh G. J., Polk A. D. THE PATHOGENESIS OF MENINGOCOCCUS MENINGITIS IN THE CHICK EMBRYO. J Exp Med. 1939 Oct 31;70(5):499–510. doi: 10.1084/jem.70.5.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Bullen J. J., Rogers H. J., Griffiths E. Role of iron in bacterial infection. Curr Top Microbiol Immunol. 1978;80:1–35. doi: 10.1007/978-3-642-66956-9_1. [DOI] [PubMed] [Google Scholar]
  34. Bumgarner L. R., Finkelstein R. A. Pathogenesis and immunology of experimental gonococcal infection: virulence of colony types of Neisseria gonorrhoeae for chicken embryos. Infect Immun. 1973 Dec;8(6):919–924. doi: 10.1128/iai.8.6.919-924.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Bundle D. R., Jennings H. J., Kenny C. P. An improved procedure for the isolation of meningococcal, polysaccharide antigens, and the structural determination of the antigen from serogroup X. Carbohydr Res. 1973 Jan;26(1):268–270. doi: 10.1016/s0008-6215(00)85053-3. [DOI] [PubMed] [Google Scholar]
  36. Bundle D. R., Jennings H. J., Kenny C. P. Studies on the group-specific polysaccharide of Neisseria meningitidis serogroup X and an improved procedure for its isolation. J Biol Chem. 1974 Aug 10;249(15):4797–4801. [PubMed] [Google Scholar]
  37. Bundle D. R., Smith I. C., Jennings H. J. Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance. Studies on the group-specific antigens of Neisseria meningitidis serogroups A and X. J Biol Chem. 1974 Apr 10;249(7):2275–2281. [PubMed] [Google Scholar]
  38. Calver G. A., Kenny C. P., Kushner D. J. Inhibition of the growth of Neisseria meningitidis by reduced ferritin and other iron-binding agents. Infect Immun. 1979 Sep;25(3):880–890. doi: 10.1128/iai.25.3.880-890.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Calver G. A., Kenny C. P., Lavergne G. Iron as a replacement for mucin in the establishment of meningococcal infection in mice. Can J Microbiol. 1976 Jun;22(6):832–838. doi: 10.1139/m76-120. [DOI] [PubMed] [Google Scholar]
  40. Carifo K., Catlin B. W. Neisseria gonorrhoeae auxotyping: differentiation of clinical isolates based on growth responses on chemically defined media. Appl Microbiol. 1973 Sep;26(3):223–230. doi: 10.1128/am.26.3.223-230.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Carpenter C. M., Charles R. Isolation of Meningococcus from the Genitourinary Tract of Seven Patients. Am J Public Health Nations Health. 1942 Jun;32(6):640–643. doi: 10.2105/ajph.32.6.640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Catlin B. W. Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing. J Infect Dis. 1973 Aug;128(2):178–194. doi: 10.1093/infdis/128.2.178. [DOI] [PubMed] [Google Scholar]
  43. Chen S. S., Walgate J. H., Duerre J. A. Oxidative deamination of sulfur amino acids by bacterial and snake venom L-amino acid oxidase. Arch Biochem Biophys. 1971 Sep;146(1):54–63. doi: 10.1016/s0003-9861(71)80040-1. [DOI] [PubMed] [Google Scholar]
  44. Cook J. A., Wise W. C., Halushka P. V. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest. 1980 Jan;65(1):227–230. doi: 10.1172/JCI109655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Coudert M. Charcterization and physiological function of a soluble L-amino acid oxidase in Corynebacterium. Arch Microbiol. 1975;102(2):151–153. doi: 10.1007/BF00428360. [DOI] [PubMed] [Google Scholar]
  46. Cox D. L., Baugh C. L. Carboxylation of phosphoenolpyruvate by extracts of Neisseria gonorrhoeae. J Bacteriol. 1977 Jan;129(1):202–206. doi: 10.1128/jb.129.1.202-206.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Craven D. E., Frasch C. E., Mocca L. F., Rose F. B., Gonzalez R. Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population. J Clin Microbiol. 1979 Sep;10(3):302–307. doi: 10.1128/jcm.10.3.302-307.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Craven D. E., Frasch C. E. Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model. Infect Immun. 1979 Oct;26(1):110–117. doi: 10.1128/iai.26.1.110-117.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Davis C. E., Arnold K. Role of meningococcal endotoxin in meningococcal purpura. J Exp Med. 1974 Jul 1;140(1):159–171. doi: 10.1084/jem.140.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Davis C. E., Ziegler E. J., Arnold K. F. Neutralization of meningococcal endotoxin by antibody to core glycolipid. J Exp Med. 1978 Apr 1;147(4):1007–1017. doi: 10.1084/jem.147.4.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. DeVoe I. W. Egestion of degraded meningococci by polymorphonuclear leukocytes. J Bacteriol. 1976 Jan;125(1):258–266. doi: 10.1128/jb.125.1.258-266.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. DeVoe I. W., Gilchrist J. E. Pili on meningococci from primary cultures of nasopharyngeal carriers and cerebrospinal fluid of patients with acute disease. J Exp Med. 1975 Feb 1;141(2):297–305. doi: 10.1084/jem.141.2.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. DeVoe I. W., Gilchrist J. E. Piliation and colonial morphology among laboratory strains of meningococci. J Clin Microbiol. 1978 Apr;7(4):379–384. doi: 10.1128/jcm.7.4.379-384.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. DeVoe I. W., Gilchrist J. E., Storm D. W. Ultrastructural studies on the fate of group B meningococci in human peripheral blood leukocytes. Can J Microbiol. 1973 Nov;19(11):1355–1359. doi: 10.1139/m73-218. [DOI] [PubMed] [Google Scholar]
  55. DeVoe I. W., Gilka F. Disseminated intravascular coagulation in rabbits: synergistic activity of meningococcal endotoxin and materials egested from leucocytes containing meningococci. J Med Microbiol. 1976 Nov;9(4):451–458. doi: 10.1099/00222615-9-4-451. [DOI] [PubMed] [Google Scholar]
  56. DeVoe I. W., Gilka F., Gilchrist J. E., Yu E. Pathology in rabbits treated with leukocyte-degraded meningococci in combination with meningococcal endotoxin. Infect Immun. 1977 Apr;16(1):271–279. doi: 10.1128/iai.16.1.271-279.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Devoe I. W., Gilchrist J. E. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J Exp Med. 1973 Nov 1;138(5):1156–1167. doi: 10.1084/jem.138.5.1156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Devoe I. W., Gilchrist J. E. Ultrastructure of pili and annular structures on the cell wall surface of Neisseria meningitidis. Infect Immun. 1974 Oct;10(4):872–876. doi: 10.1128/iai.10.4.872-876.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Devoe I. W., Golchrist J. E. Localization of tetramethylphenylenediamine-oxidase in the outer cell wall layer of Neisseria meningitidis. J Bacteriol. 1976 Oct;128(1):144–148. doi: 10.1128/jb.128.1.144-148.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Diena B. B., Lavergne G., Ryan A., Ashton F., Wallace R. Transmission of immunity to Neisseria gonorrhoeae from vaccinated hens to embryos. Immunol Commun. 1976;5(1-2):69–73. doi: 10.3109/08820137609020613. [DOI] [PubMed] [Google Scholar]
  61. Ducker T. B., Simmons R. L. The pathogenesis of meningitis. Systemic effect of meningococcal endotoxin within the cerebrospinal fluid. Arch Neurol. 1968 Feb;18(2):123–128. doi: 10.1001/archneur.1968.00470320025002. [DOI] [PubMed] [Google Scholar]
  62. Duerre J. A., Chakrabarty S. l-amino acid oxidases of Proteus rettgeri. J Bacteriol. 1975 Feb;121(2):656–663. doi: 10.1128/jb.121.2.656-663.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. ECKMAN P. L., KING W. M., BRUNSON J. G. Studies on the blood brain barrier. I. Effects produced by a single injection of gramnegative endotoxin on the permeability of the cerebral vessels. Am J Pathol. 1958 Jul-Aug;34(4):631–643. [PMC free article] [PubMed] [Google Scholar]
  64. Elin R. J., Wolff S. M. Biology of endotoxin. Annu Rev Med. 1976;27:127–141. doi: 10.1146/annurev.me.27.020176.001015. [DOI] [PubMed] [Google Scholar]
  65. Evans B. A. Ultrastructural study of cervical gonorrhea. J Infect Dis. 1977 Aug;136(2):248–255. doi: 10.1093/infdis/136.2.248. [DOI] [PubMed] [Google Scholar]
  66. Evans R. T., Spaeth S., Mergenhagen S. E. Bactericidal antibody in mammalian serum to obligatorily anaerobic Gram-negative bacteria. J Immunol. 1966 Jul;97(1):112–119. [PubMed] [Google Scholar]
  67. FERGUSON J. H., CHAPMAN O. D. Fulminating meningococcic infections and the so-called Waterhouse-Friderichsen syndrome. Am J Pathol. 1948 Jul;24(4):763–795. [PMC free article] [PubMed] [Google Scholar]
  68. FINKELSTEIN R. A. OBSERVATIONS ON MODE OF ACTION OF ENDOTOXIN IN CHICK EMBRYOS. Proc Soc Exp Biol Med. 1964 Mar;115:702–707. doi: 10.3181/00379727-115-29012. [DOI] [PubMed] [Google Scholar]
  69. Farquhar J. D., Hankins W. A., DeSanctis A. N., DeMeio J. L., Metzgar D. P. Clinical and serological evaluation of purified polysaccharide vaccines prepared from Neisseria meningitidis group Y. Proc Soc Exp Biol Med. 1977 Sep;155(4):453–455. doi: 10.3181/00379727-155-39828. [DOI] [PubMed] [Google Scholar]
  70. Faur Y. C., Weisburd M. H., Wilson M. E. Isolation of Neisseria meningitidis from the Genito-urinary tract and anal canal. J Clin Microbiol. 1975 Sep;2(3):178–182. doi: 10.1128/jcm.2.3.178-182.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Finkelstein R. A., Yancey R. J. Effect of siderophores on virulence of Neisseria gonorrhoeae. Infect Immun. 1981 May;32(2):609–613. doi: 10.1128/iai.32.2.609-613.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Flexner S. EXPERIMENTAL CEREBRO-SPINAL MENINGITIS IN MONKEYS. J Exp Med. 1907 Mar 14;9(2):142–167. doi: 10.1084/jem.9.2.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Frank S. T., Gomez R. M. Chronic meningococcemia. Mil Med. 1968 Nov;133(11):918–920. [PubMed] [Google Scholar]
  74. Frasch C. E., Chapman S. S. Classification of Neisseria meningitidis group B into distinct serotypes. 3. Application of a new bactericidal-inhibition technique to distribution of serotypes among cases and carriers. J Infect Dis. 1973 Feb;127(2):149–154. doi: 10.1093/infdis/127.2.149. [DOI] [PubMed] [Google Scholar]
  75. Frasch C. E., McNelis R. M., Gotschlich E. C. Strain-specific variation in the protein and lipopolysaccharide composition of the group B meningococcal outer membrane. J Bacteriol. 1976 Aug;127(2):973–981. doi: 10.1128/jb.127.2.973-981.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Frasch C. E., Parkes L., McNelis R. M., Gotschlich E. C. Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model. J Exp Med. 1976 Aug 1;144(2):319–329. doi: 10.1084/jem.144.2.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Frasch C. E., Robbins J. D. Protection against group B meningococcal disease. II. Infection and resulting immunity in a guinea pig model. J Exp Med. 1978 Mar 1;147(3):619–628. doi: 10.1084/jem.147.3.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Frasch C. E., Robbins J. D. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. J Exp Med. 1978 Mar 1;147(3):629–644. doi: 10.1084/jem.147.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Frasch C. E. Role of protein serotype antigens in protection against disease due to Neisseria meningitidis. J Infect Dis. 1977 Aug;136 (Suppl):S84–S90. doi: 10.1093/infdis/136.supplement.s84. [DOI] [PubMed] [Google Scholar]
  80. Frisch A. W. The meningococcidal power of heparinized blood for group B organisms. Am J Clin Pathol. 1968 Aug;50(2):221–228. doi: 10.1093/ajcp/50.2.221. [DOI] [PubMed] [Google Scholar]
  81. Froholm L. O., Jyssum K., Bovre K. Electron microscopical and cultural features of Neisseria meningitidis competence variants. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Oct;81(5):525–537. doi: 10.1111/j.1699-0463.1973.tb02238.x. [DOI] [PubMed] [Google Scholar]
  82. Froholm L. O., Sletten K. Purification and N-terminal sequence of a fimbrial protein from Moraxella nonliquefaciens. FEBS Lett. 1977 Jan 15;73(1):29–32. doi: 10.1016/0014-5793(77)80008-2. [DOI] [PubMed] [Google Scholar]
  83. Glover J. A. "SPACING OUT" IN THE PREVENTION OF MILITARY EPIDEMICS OF CEREBRO-SPINAL FEVER. Br Med J. 1918 Nov 9;2(3019):509–512. doi: 10.1136/bmj.2.3019.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Gold R., Artenstein M. S. Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. Bull World Health Organ. 1971;45(3):279–282. [PMC free article] [PubMed] [Google Scholar]
  85. Gold R., Goldschneider I., Lepow M. L., Draper T. F., Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis. 1978 Feb;137(2):112–121. doi: 10.1093/infdis/137.2.112. [DOI] [PubMed] [Google Scholar]
  86. Gold R., Lepow M. L., Goldschneider I., Draper T. F., Gotschlich E. C. Antibody responses of human infants to three doses of group A Neisseria meningitidis polysaccharide vaccine administered at two, four, and six months of age. J Infect Dis. 1978 Dec;138(6):731–735. doi: 10.1093/infdis/138.6.731. [DOI] [PubMed] [Google Scholar]
  87. Gold R., Lepow M. L., Goldschneider I., Draper T. F., Gotshlich E. C. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. J Infect Dis. 1979 Nov;140(5):690–697. doi: 10.1093/infdis/140.5.690. [DOI] [PubMed] [Google Scholar]
  88. Gold R., Lepow M. L., Goldschneider I., Gotschlich E. C. Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis. J Infect Dis. 1977 Aug;136 (Suppl):S31–S35. doi: 10.1093/infdis/136.supplement.s31. [DOI] [PubMed] [Google Scholar]
  89. Gold R., Lepow M. L. Present status of polysaccharide vaccines in the prevention of meningococcal disease. Adv Pediatr. 1976;23:71–93. [PubMed] [Google Scholar]
  90. Gold R., Winklehake J. L., Mars R. S., Artenstein M. S. Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping. J Infect Dis. 1971 Dec;124(6):593–597. doi: 10.1093/infdis/124.6.593. [DOI] [PubMed] [Google Scholar]
  91. Gold R., Wyle F. A. New Classification of Neisseria meningitidis by Means of Bactericidal Reactions. Infect Immun. 1970 May;1(5):479–484. doi: 10.1128/iai.1.5.479-484.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969 Jun 1;129(6):1307–1326. doi: 10.1084/jem.129.6.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Goldstein E., Buhles W. C., Akers T. G., Vedros N. Murine resistance to inhaled Neisseria meningitidis after infection with an encephalomyocarditis virus. Infect Immun. 1972 Sep;6(3):398–402. doi: 10.1128/iai.6.3.398-402.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Gotschlich E. C., Goldschneider I., Artenstein M. S. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med. 1969 Jun 1;129(6):1367–1384. doi: 10.1084/jem.129.6.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Gotschlich E. C., Goldschneider I., Artenstein M. S. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med. 1969 Jun 1;129(6):1385–1395. doi: 10.1084/jem.129.6.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Gregorius F. K., Johnson B. L., Jr, Stern W. E., Brown W. J. Pathologenesis of hematogenous bacterial meningitis in rabbits. J Neurosurg. 1976 Nov;45(5):561–567. doi: 10.3171/jns.1976.45.5.0561. [DOI] [PubMed] [Google Scholar]
  97. Griffiss J. M. Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera. J Immunol. 1975 Jun;114(6):1779–1784. [PubMed] [Google Scholar]
  98. Griffiss J. M., Bertram M. A. Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease. J Infect Dis. 1977 Dec;136(6):733–739. doi: 10.1093/infdis/136.6.733. [DOI] [PubMed] [Google Scholar]
  99. Griffiss J. M., Broud D. D., Silver C. A., Artenstein M. S. Immunoepidemiology of meningococcal disease in military recruits. I. A model for serogroup independency of epidemic potential as determined by serotyping. J Infect Dis. 1977 Aug;136(2):176–186. doi: 10.1093/infdis/136.2.176. [DOI] [PubMed] [Google Scholar]
  100. Griffiss J. M., Goroff D. K. Immunological cross-reaction between a naturally occurring galactan, agarose, and an LPS locus for immune lysis of Neisseria meningitidis by human sera. Clin Exp Immunol. 1981 Jan;43(1):20–27. [PMC free article] [PubMed] [Google Scholar]
  101. HARTER D. H., PETERSDORF R. G. A consideration of the pathogenesis of bacterial meningitis: review of experimental and clinical studies. Yale J Biol Med. 1960 Feb;32:280–309. [PMC free article] [PubMed] [Google Scholar]
  102. HJORT P. F., RAPAPORT S. I. THE SHWARTZMAN REACTION: PATHOGENETIC MECHANISMS AND CLINICAL MANIFESTATIONS. Annu Rev Med. 1965;16:135–168. doi: 10.1146/annurev.me.16.020165.001031. [DOI] [PubMed] [Google Scholar]
  103. Hackenthal E. Distribution of keto-deoxyoctonic acid and sialic acid in N. meningitidis. J Immunol. 1969 Apr;102(4):1099–1102. [PubMed] [Google Scholar]
  104. Hansson H. A., Johansson B., Blomstrand C. Ultrastructural studies on cerebrovascular permeability in acute hypertension. Acta Neuropathol. 1975 Aug 27;32(3):187–198. doi: 10.1007/BF00696568. [DOI] [PubMed] [Google Scholar]
  105. Haverkamp J., Meuzelaar H. L., Beuvery E. C., Boonekamp P. M., Tiesjema R. H. Characterization of Neisseria meningitidis capsular polysaccharides containing sialic acid by pyrolysis mass spectrometry. Anal Biochem. 1980 May 15;104(2):407–418. doi: 10.1016/0003-2697(80)90092-5. [DOI] [PubMed] [Google Scholar]
  106. Hawiger J., Hawiger A., Steckley S., Timmons S., Cheng C. Membrane changes in human platelets induced by lipopolysaccharide endotoxin. Br J Haematol. 1977 Feb;35(2):285–299. doi: 10.1111/j.1365-2141.1977.tb00585.x. [DOI] [PubMed] [Google Scholar]
  107. Hebeler B. H., Morse S. A. Physiology and metabolism of pathogenic neisseria: tricarboxylic acid cycle activity in Neisseria gonorrhoeae. J Bacteriol. 1976 Oct;128(1):192–201. doi: 10.1128/jb.128.1.192-201.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Hermodson M. A., Chen K. C., Buchanan T. M. Neisseria pili proteins: amino-terminal amino acid sequences and identification of an unusual amino acid. Biochemistry. 1978 Feb 7;17(3):442–445. doi: 10.1021/bi00596a010. [DOI] [PubMed] [Google Scholar]
  109. Hill J. C., Weiss E. Protein fraction with immunogenic potential and low toxicity isolated from the cell wall of Neisseria meningitidis group B. Infect Immun. 1974 Sep;10(3):605–615. doi: 10.1128/iai.10.3.605-615.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Hobbs J. R., Milner R. D., Watt P. J. Gamma-M deficiency predisposing to meningococcal septicaemia. Br Med J. 1967 Dec 9;4(5579):583–586. doi: 10.1136/bmj.4.5579.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Holbein B. E. Differences in virulence for mice between disease and carrier strains of Neisseria meningitidis. Can J Microbiol. 1981 Jul;27(7):738–741. doi: 10.1139/m81-113. [DOI] [PubMed] [Google Scholar]
  112. Holbein B. E. Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin. Infect Immun. 1981 Oct;34(1):120–125. doi: 10.1128/iai.34.1.120-125.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Holbein B. E. Iron-controlled infection with Neisseria meningitidis in mice. Infect Immun. 1980 Sep;29(3):886–891. doi: 10.1128/iai.29.3.886-891.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Holbein B. E., Jericho K. W., Likes G. C. Neisseria meningitidis infection in mice: influence of iron, variations in virulence among strains, and pathology. Infect Immun. 1979 May;24(2):545–551. doi: 10.1128/iai.24.2.545-551.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Holten E. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J Clin Microbiol. 1979 Feb;9(2):186–188. doi: 10.1128/jcm.9.2.186-188.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Horn R. G., Collins R. D. Studies on the pathogenesis of the generalized Schwartzman reaction. The role of granulocytes. Lab Invest. 1968 Feb;18(2):101–107. [PubMed] [Google Scholar]
  117. Jacobs S. A., Norden C. W. Pneumonia caused by Neisseria meningitidis. JAMA. 1974 Jan 7;227(1):67–68. [PubMed] [Google Scholar]
  118. Jacobson J. A., Chester T. J., Fraser D. W. An epidemic of disease due to serogroup B Neisseria meningitidis in Alabama: report of an investigation and community-wide prophylaxis with a sulfonamide. J Infect Dis. 1977 Jul;136(1):104–108. doi: 10.1093/infdis/136.1.104. [DOI] [PubMed] [Google Scholar]
  119. Jacobson J. A., Frasch C. E. Meningococcal disease in Alabama. J Infect Dis. 1978 Mar;137(3):375–375. doi: 10.1093/infdis/137.3.375. [DOI] [PubMed] [Google Scholar]
  120. Jennings H. J., Bhattacharjee A. K., Kenne L., Kenny C. P., Calver G. The R-type lipopolysaccharides of Neisseria meningitidis. Can J Biochem. 1980 Feb;58(2):128–136. doi: 10.1139/o80-018. [DOI] [PubMed] [Google Scholar]
  121. Jennings H. J., Hawes G. B., Adams G. A., Kenny C. P. The chemical composition and serological reactions of lipopolysaccharides from serogroups A,B,X, and Y Neisseria meningitidis. Can J Biochem. 1973 Oct;51(10):1347–1354. doi: 10.1139/o73-178. [DOI] [PubMed] [Google Scholar]
  122. Jephcott A. E., Reyn A., Birch-Andersen A. Neisseria gonorrhoeae 3. Demonstration of presumed appendages to cells from different colony types. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;79(3):437–439. doi: 10.1111/j.1699-0463.1971.tb00086.x. [DOI] [PubMed] [Google Scholar]
  123. Jones D. M., Tobin B. M., Butterworth A. Three cases of meningococcal infection in a family, associated with a deficient immune response. Arch Dis Child. 1973 Sep;48(9):742–743. doi: 10.1136/adc.48.9.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Jones D. M., Tobin B. M. Serotypes of group B meningococci. J Clin Pathol. 1976 Aug;29(8):746–748. doi: 10.1136/jcp.29.8.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Jurtshuk P., Jr, Mueller T. J., Acord W. C. Bacterial terminal oxidases. CRC Crit Rev Microbiol. 1975 May;3(4):399–468. doi: 10.3109/10408417509108757. [DOI] [PubMed] [Google Scholar]
  126. Jurtshuk P., Milligan T. W. Quantitation of the tetramethyl-p-phenylenediamine oxidase reaction in Neisseria species. Appl Microbiol. 1974 Dec;28(6):1079–1081. doi: 10.1128/am.28.6.1079-1081.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. KELLOGG D. S., Jr, PEACOCK W. L., Jr, DEACON W. E., BROWN L., PIRKLE D. I. NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION. J Bacteriol. 1963 Jun;85:1274–1279. doi: 10.1128/jb.85.6.1274-1279.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Kabat E. A., Kaiser H., Sikorski H. PREPARATION OF THE TYPE-SPECIFIC POLYSACCHARIDE OF THE TYPE I MENINGOCOCCUS AND A STUDY OF ITS EFFECTIVENESS AS AN ANTIGEN IN HUMAN BEINGS. J Exp Med. 1944 Oct 1;80(4):299–307. doi: 10.1084/jem.80.4.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Karolus J. J., Gandelman A. L., Nolan B. A. Urethritis caused by Neisseria meningitidis. J Clin Microbiol. 1980 Aug;12(2):284–285. doi: 10.1128/jcm.12.2.284-285.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Kasper D. L., Winkelhake J. L., Zollinger W. D., Brandt B. L., Artenstein M. S. Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. J Immunol. 1973 Jan;110(1):262–268. [PubMed] [Google Scholar]
  131. Kellogg D. S., Jr, Cohen I. R., Norins L. C., Schroeter A. L., Reising G. Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol. 1968 Sep;96(3):596–605. doi: 10.1128/jb.96.3.596-605.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Kenimer E. A., Lapp D. F. Effects of selected inhibitors on electron transport in Neisseria gonorrhoeae. J Bacteriol. 1978 May;134(2):537–545. doi: 10.1128/jb.134.2.537-545.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. LAL H. B., NARAYAN T. K., KALRA S. L., LAL R. Simultaneous outbreaks of influenza and meningitis. J Indian Med Assoc. 1963 Feb 1;40:113–115. [PubMed] [Google Scholar]
  134. Le Faou A. Etude du métabolisme des formes minérales du soufre chez Neisseria gonorrhoeae : mise en évidence d'une thiosulfate réductase. C R Seances Acad Sci III. 1981 Apr 6;292(14):851-3, 855-6. [PubMed] [Google Scholar]
  135. Lee T. J., Snyderman R., Patterson J., Rauchbach A. S., Folds J. D., Yount W. J. Neisseria meningitidis bacteremia in association with deficiency of the sixth component of complement. Infect Immun. 1979 Jun;24(3):656–660. doi: 10.1128/iai.24.3.656-660.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Lee T. J., Utsinger P. D., Snyderman R., Yount W. J., Sparling P. F. Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria. J Infect Dis. 1978 Sep;138(3):359–368. doi: 10.1093/infdis/138.3.359. [DOI] [PubMed] [Google Scholar]
  137. Lepow M. L., Gold R. Current status of vaccines against the meningococcus. Prev Med. 1974 Dec;3(4):449–455. doi: 10.1016/0091-7435(74)90006-1. [DOI] [PubMed] [Google Scholar]
  138. Lim D., Gewurz A., Lint T. F., Ghaze M., Sepheri B., Gewurz H. Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis. J Pediatr. 1976 Jul;89(1):42–47. doi: 10.1016/s0022-3476(76)80924-9. [DOI] [PubMed] [Google Scholar]
  139. Limjuco G. A., Karkhanis Y. D., Zeltner J. Y., Maigetter R. Z., King J. J., Carlo D. J. Studies on the chemical composition of lipopolysaccharide from Neisseria meningitidis group B. J Gen Microbiol. 1978 Feb;104(2):187–191. doi: 10.1099/00221287-104-2-187. [DOI] [PubMed] [Google Scholar]
  140. Littlejohns W. A. The enigma of the meningococcus. J Antimicrob Chemother. 1977 Jan;3(1):9–16. doi: 10.1093/jac/3.1.9. [DOI] [PubMed] [Google Scholar]
  141. Liu T. Y., Gotschlich E. C., Dunne F. T., Jonssen E. K. Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide. J Biol Chem. 1971 Aug 10;246(15):4703–4712. [PubMed] [Google Scholar]
  142. Liu T. Y., Gotschlich E. C., Jonssen E. K., Wysocki J. R. Studies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A polysaccharide. J Biol Chem. 1971 May 10;246(9):2849–2858. [PubMed] [Google Scholar]
  143. Lowell G. H., Smith L. F., Artenstein M. S., Nash G. S., MacDermott R. P., Jr Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera. J Exp Med. 1979 Jul 1;150(1):127–137. doi: 10.1084/jem.150.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Lowell G. H., Smith L. F., Griffiss J. M., Brandt B. L., MacDermott R. P. Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A. J Clin Invest. 1980 Aug;66(2):260–267. doi: 10.1172/JCI109852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. MARGARETTEN W., McADAMS A. J. An appraisal of fulminant meningococcemia with reference to the Shartzman phenomenon. Am J Med. 1958 Dec;25(6):868–876. doi: 10.1016/0002-9343(58)90059-7. [DOI] [PubMed] [Google Scholar]
  146. MARGARETTEN W., NAKAI H., LANDING B. H. Septicemic adrenal hemorrhage. Am J Dis Child. 1963 Apr;105:346–351. doi: 10.1001/archpedi.1963.02080040348004. [DOI] [PubMed] [Google Scholar]
  147. MICHAEL J. G., ROSEN F. S. ASSOCIATION OF "NATURAL" ANTIBODIES TO GRAM-NEGATIVE BACTERIA WITH THE GAMMA-1-MACROGLOBULINS. J Exp Med. 1963 Oct 1;118:619–626. doi: 10.1084/jem.118.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. MICHAEL J. G., WHITBY J. L., LANDY M. Studies on natural antibodies to gram-negative bacteria. J Exp Med. 1962 Jan 1;115:131–146. doi: 10.1084/jem.115.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. MacLeod M. N., DeVoe I. W. Localization of carbonic anhydrase in the cytoplasmic membrane of Neisseria sicca (strain 19). Can J Microbiol. 1981 Jan;27(1):87–92. doi: 10.1139/m81-014. [DOI] [PubMed] [Google Scholar]
  150. Mandrell R. E., Zollinger W. D. Lipopolysaccharide serotyping of Neisseria meningitidis by hemagglutination inhibition. Infect Immun. 1977 May;16(2):471–475. doi: 10.1128/iai.16.2.471-475.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Margaretten W., Csavossy I., McKay D. G. An electron miscroscope study of a case of meningococcemia in man. Am J Dis Child. 1967 Sep;114(3):268–277. doi: 10.1001/archpedi.1967.02090240082005. [DOI] [PubMed] [Google Scholar]
  152. McDonald I. J., Adams G. A. Influence of cultural conditions on the lipopolysaccharide composition of Neisseria sicca. J Gen Microbiol. 1971 Feb;65(2):201–207. doi: 10.1099/00221287-65-2-201. [DOI] [PubMed] [Google Scholar]
  153. McDonald I. J., Johnson K. G. Nutritional requirements of some non-pathogenic Neisseria grown in simple synthetic media. Can J Microbiol. 1975 Aug;21(8):1198–1204. doi: 10.1139/m75-179. [DOI] [PubMed] [Google Scholar]
  154. McGee Z. A., Dourmashkin R. R., Gross J. G., Clark J. B., Taylor-Robinson D. Relationship of pili to colonial morphology among pathogenic and nonpathogenic species of Neisseria. Infect Immun. 1977 Feb;15(2):594–600. doi: 10.1128/iai.15.2.594-600.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. McGee Z. A., Street C. H., Chappell C. L., Cousar E. S., Morris F., Horn R. G. Pili of Neisseria meningitidis: effect of media on maintenance of piliation, characteristics of Pili, and colonial morphology. Infect Immun. 1979 Apr;24(1):194–201. doi: 10.1128/iai.24.1.194-201.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. McGehee W. G., Rapaport S. I., Hjort P. F. Intravascular coagulation in fulminant meningococcemia. Ann Intern Med. 1967 Aug;67(2):250–260. doi: 10.7326/0003-4819-67-2-250. [DOI] [PubMed] [Google Scholar]
  157. McLoughlin G. A., Wu A. V., Saporoschetz I., Nimberg R., Mannick J. A. Correlation between anergy and a circulating immunosuppressive factor following major surgical trauma. Ann Surg. 1979 Sep;190(3):297–304. doi: 10.1097/00000658-197909000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Mickelsen P. A., Blackman E., Sparling P. F. Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin. Infect Immun. 1982 Mar;35(3):915–920. doi: 10.1128/iai.35.3.915-920.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Mickelsen P. A., Sparling P. F. Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds. Infect Immun. 1981 Aug;33(2):555–564. doi: 10.1128/iai.33.2.555-564.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Miller C. P. EXPERIMENTAL MENINGOCOCCAL INFECTION IN MICE. Science. 1933 Oct 13;78(2024):340–341. doi: 10.1126/science.78.2024.340. [DOI] [PubMed] [Google Scholar]
  161. Miller M. A., Millikin P., Griffin P. S., Sexton R. A., Yousuf M. Neisseria meningitidis urethritis. A case report. JAMA. 1979 Oct 12;242(15):1656–1657. [PubMed] [Google Scholar]
  162. Morse S. A., Cacciapuoti A. F., Lysko P. G. Physiology of Neisseria gonorrhoeae. Adv Microb Physiol. 1979;20:251–320. doi: 10.1016/s0065-2911(08)60209-x. [DOI] [PubMed] [Google Scholar]
  163. Morse S. A., Hebeler B. H. Effect of pH on the growth and glucose metabolism of Neisseria gonorrhoeae. Infect Immun. 1978 Jul;21(1):87–95. doi: 10.1128/iai.21.1.87-95.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Mulks M. H., Plaut A. G., Feldman H. A., Frangione B. IgA proteases of two distinct specificities are released by Neisseria meningitidis. J Exp Med. 1980 Nov 1;152(5):1442–1447. doi: 10.1084/jem.152.5.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Mulks M. H., Plaut A. G. IgA protease production as a characteristic distinguishing pathogenic from harmless neisseriaceae. N Engl J Med. 1978 Nov 2;299(18):973–976. doi: 10.1056/NEJM197811022991802. [DOI] [PubMed] [Google Scholar]
  166. Munford R. S., Patton C. M., Gorman G. W. Epidemiologic studies of serotype antigens common to groups B and C Neisseria meningitidis. J Infect Dis. 1975 Mar;131(3):286–290. doi: 10.1093/infdis/131.3.286. [DOI] [PubMed] [Google Scholar]
  167. Mäkelä P. H., Peltola H., Käyhty H., Jousimies H., Pettay O., Ruoslahti E., Sivonen A., Renkonen O. V. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis. 1977 Aug;136 (Suppl):S43–S50. doi: 10.1093/infdis/136.supplement.s43. [DOI] [PubMed] [Google Scholar]
  168. Nicholson A., Lepow I. H. Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity. Science. 1979 Jul 20;205(4403):298–299. doi: 10.1126/science.451601. [DOI] [PubMed] [Google Scholar]
  169. Novotny P., Short J. A., Walker P. D. An electron-microscope study of naturally occurring and cultured cells of Neisseria Gonorrhoeae. J Med Microbiol. 1975 Aug;8(3):413–427. doi: 10.1099/00222615-8-3-413. [DOI] [PubMed] [Google Scholar]
  170. Novotny P., Turner W. H. Immunological heterogeneity of pili of Neisseria gonorrhoeae. J Gen Microbiol. 1975 Jul;89(1):87–92. doi: 10.1099/00221287-89-1-87. [DOI] [PubMed] [Google Scholar]
  171. OGNIBENE A. J., DITO W. R. CHRONIC MENINGOCOCCEMIA. FURTHER COMMENTS ON THE PATHOGENESIS OF ASSOCIATED SKIN LESIONS. Arch Intern Med. 1964 Jul;114:29–32. doi: 10.1001/archinte.1964.03860070075005. [DOI] [PubMed] [Google Scholar]
  172. Odegaard K., Gedde-Dahl T. W. Frequency of simultaneous carriage of Neisseria gonorrhoeae and Neisseria meningitidis. Br J Vener Dis. 1979 Oct;55(5):334–335. doi: 10.1136/sti.55.5.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Olsson Y., Hossmann K. A. Fine structural localization of exudated protein tracers in the brain. Acta Neuropathol. 1970;16(2):103–116. doi: 10.1007/BF00687665. [DOI] [PubMed] [Google Scholar]
  174. Payne S. M., Finkelstein R. A. The critical role of iron in host-bacterial interactions. J Clin Invest. 1978 Jun;61(6):1428–1440. doi: 10.1172/JCI109062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Pelmont J., Arlaud G., Rossat A. M. L-aminoacide oxydases des enveloppes de Proteus mirabilis: propriétés générales. Biochimie. 1972;54(10):1359–1374. doi: 10.1016/s0300-9084(72)80076-2. [DOI] [PubMed] [Google Scholar]
  176. Peltola H., Mäkelä H., Käyhty H., Jousimies H., Herva E., Hällström K., Sivonen A., Renkonen O. V., Pettay O., Karanko V. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med. 1977 Sep 29;297(13):686–691. doi: 10.1056/NEJM197709292971302. [DOI] [PubMed] [Google Scholar]
  177. Peter G., Weigert M. B., Bissel A. R., Gold R., Kreutzer D., McLean R. H. Meningococcal meningitis in familial deficiency of the fifth component of complement. Pediatrics. 1981 Jun;67(6):882–886. [PubMed] [Google Scholar]
  178. Petersen B. H., Graham J. A., Brooks G. F. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity. J Clin Invest. 1976 Feb;57(2):283–290. doi: 10.1172/JCI108279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Petersen B. H., Lee T. J., Snyderman R., Brooks G. F. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med. 1979 Jun;90(6):917–920. doi: 10.7326/0003-4819-90-6-917. [DOI] [PubMed] [Google Scholar]
  180. Plaut A. G., Gilbert J. V., Artenstein M. S., Capra J. D. Neisseria gonorrhoeae and neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A. Science. 1975 Dec 12;190(4219):1103–1105. doi: 10.1126/science.810892. [DOI] [PubMed] [Google Scholar]
  181. Plaut A. G., Gilbert J. V., Wistar R., Jr Loss of antibody activity in human immunoglobulin A exposed extracellular immunoglobulin A proteases of Neisseria gonorrhoeae and Streptococcus sanguis. Infect Immun. 1977 Jul;17(1):130–135. doi: 10.1128/iai.17.1.130-135.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Poolman J. T., Hopman C. T., Zanen H. C. Immunochemical characterization of Neisseria meningitidis serotype antigens by immunodiffusion and SDS-polyacrylamide gel electrophoresis immunoperoxidase techniques and the distribution of serotypes among cases and carriers. J Gen Microbiol. 1980 Feb;116(2):465–473. doi: 10.1099/00221287-116-2-465. [DOI] [PubMed] [Google Scholar]
  183. Pribnow J. F., Hall J. M., Bradley D., Vedros N. A. Cellular Response of the Rabbit Eye to Primary Intravitreal Injection of Neisseria meningitidis. Infect Immun. 1971 Jun;3(6):739–746. doi: 10.1128/iai.3.6.739-746.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Pribnow J. F., Hall J. M., Stewart R. H., Vedros N. A. The ocular inflammation produced following intravitreal injection of a stable L-phase variant of Neisseria meningitidis. Can J Ophthalmol. 1973 Apr;8(2):361–365. [PubMed] [Google Scholar]
  185. Public Health Weekly Reports for AUGUST 12, 1932. Public Health Rep. 1932 Aug 12;47(33):1683–1721. [PMC free article] [PubMed] [Google Scholar]
  186. Public Health Weekly Reports for AUGUST 20, 1937. Public Health Rep. 1937 Aug 20;52(34):1135–1167. [PMC free article] [PubMed] [Google Scholar]
  187. Public Health Weekly Reports for NOVEMBER 4, 1932. Public Health Rep. 1932 Nov 4;47(45):2137–2158. [PMC free article] [PubMed] [Google Scholar]
  188. Putsch R. W., Hamilton J. D., Wolinsky E. Neisseria meningitidis, a respiratory pathogen? J Infect Dis. 1970 Jan;121(1):48–54. doi: 10.1093/infdis/121.1.48. [DOI] [PubMed] [Google Scholar]
  189. Quan A. L., Sippel J. E. Evaluation of bactericidal assay in serotyping Neisseria meningitidis group A. Can J Microbiol. 1979 Aug;25(8):929–931. doi: 10.1139/m79-139. [DOI] [PubMed] [Google Scholar]
  190. RORKE L. B., PITTS F. W. Purulent meningitis: the pathologic basis of clinical manifestations. Clin Pediatr (Phila) 1963 Feb;2:64–71. doi: 10.1177/000992286300200205. [DOI] [PubMed] [Google Scholar]
  191. Reller L. B., MacGregor R. R., Beaty H. N. Bactericidal antibody after colonization with Neisseria meningitidis. J Infect Dis. 1973 Jan;127(1):56–62. doi: 10.1093/infdis/127.1.56. [DOI] [PubMed] [Google Scholar]
  192. Richardson W. P., Sadoff J. C. Production of a capsule of Neisseria gonorrhoeae. Infect Immun. 1977 Feb;15(2):663–664. doi: 10.1128/iai.15.2.663-664.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Roberts R. B. The interaction in vitro between group B meningococci and rabbit polymorphonuclear leukocytes. Demonstration of type specific opsonins and bactericidins. J Exp Med. 1967 Nov 1;126(5):795–818. doi: 10.1084/jem.126.5.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Roberts R. B. The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man. J Exp Med. 1970 Mar 1;131(3):499–513. doi: 10.1084/jem.131.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Robinson J. A., Apicella M. A. Isolation and Characterization of Neisseria meningitidis Groups A, C, X, and Y Polysaccharide Antigens. Infect Immun. 1970 Jan;1(1):8–14. doi: 10.1128/iai.1.1.8-14.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Rogers H. J. Iron-Binding Catechols and Virulence in Escherichia coli. Infect Immun. 1973 Mar;7(3):445–456. doi: 10.1128/iai.7.3.445-456.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Russell R. R., Johnson K. G., McDonald I. J. Envelope proteins in Neisseria. Can J Microbiol. 1975 Oct;21(10):1519–1534. doi: 10.1139/m75-224. [DOI] [PubMed] [Google Scholar]
  198. SCHERP H. W. Neisseria and neisserial infections. Annu Rev Microbiol. 1955;9:319–334. doi: 10.1146/annurev.mi.09.100155.001535. [DOI] [PubMed] [Google Scholar]
  199. SMITH E. S. Purulent meningitis in infants and children; a review of 409 cases. J Pediatr. 1954 Oct;45(4):425–436. doi: 10.1016/s0022-3476(54)80167-3. [DOI] [PubMed] [Google Scholar]
  200. SWARTZ M. N., DODGE P. R. BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. 1. GENERAL CLINICAL FEATURES, SPECIAL PROBLEMS AND UNUSUAL MENINGEAL REACTIONS MIMICKING BACTERIAL MENINGITIS. N Engl J Med. 1965 Apr 22;272:842–CONTD. doi: 10.1056/NEJM196504222721607. [DOI] [PubMed] [Google Scholar]
  201. SWARTZ M. N., DODGE P. R. BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. 1. GENERAL CLINICAL FEATURES, SPECIAL PROBLEMS AND UNUSUAL MENINGEAL REACTIONS MIMICKING BACTERIAL MENINGITIS. N Engl J Med. 1965 Apr 8;272:725–CONTD. doi: 10.1056/NEJM196504082721406. [DOI] [PubMed] [Google Scholar]
  202. Salari S. H., DeVoe I. W., Powell W. S. Inhibition of leukotriene B4 synthesis in human polymorphonuclear leukocytes after exposure to meningococcal lipopolysaccharide. Biochem Biophys Res Commun. 1982 Feb 26;104(4):1517–1524. doi: 10.1016/0006-291x(82)91423-1. [DOI] [PubMed] [Google Scholar]
  203. Salit I. E., Morton G. Adherence of Neisseria meningitidis to human epithelial cells. Infect Immun. 1981 Jan;31(1):430–435. doi: 10.1128/iai.31.1.430-435.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Samuelsson B., Goldyne M., Granström E., Hamberg M., Hammarström S., Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978;47:997–1029. doi: 10.1146/annurev.bi.47.070178.005025. [DOI] [PubMed] [Google Scholar]
  205. Sanders E., Maren T. H. Inhibition of carbonic anhydrase in Neisseria: effects on enzyme activity and growth. Mol Pharmacol. 1967 Mar;3(2):204–215. [PubMed] [Google Scholar]
  206. Schaad U. B. Arthritis in disease due to Neisseria meningitidis. Rev Infect Dis. 1980 Nov-Dec;2(6):880–888. doi: 10.1093/clinids/2.6.880. [DOI] [PubMed] [Google Scholar]
  207. Simonson C., Brener D., DeVoe I. W. Expression of a high-affinity mechanism for acquisition of transferrin iron by Neisseria meningitidis. Infect Immun. 1982 Apr;36(1):107–113. doi: 10.1128/iai.36.1.107-113.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Simonson C., Trivett T., DeVoe I. W. Energy-independent uptake of iron from citrate by isolated outer membranes of Neisseria meningitidis. Infect Immun. 1981 Feb;31(2):547–553. doi: 10.1128/iai.31.2.547-553.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Sippel J. E., Quan A. Homogeneity of protein serotype antigens in Neisseria meningitidis group A. Infect Immun. 1977 May;16(2):623–627. doi: 10.1128/iai.16.2.623-627.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. Souza de Morais J., Munford R. S., Risi J. B., Antezana E., Feldman R. A. Epidemic disease due to serogroup C Neisseria meningitidis in Saõ Paulo, Brazil. J Infect Dis. 1974 May;129(5):568–571. doi: 10.1093/infdis/129.5.568. [DOI] [PubMed] [Google Scholar]
  211. Springer G. F., Adye J. C. Endotoxin-binding substances from human leukocytes and platelets. Infect Immun. 1975 Nov;12(5):978–986. doi: 10.1128/iai.12.5.978-986.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Stead A., Main J. S., Ward M. E., Watt P. J. Studies on lipopolysaccharides isolated from strains of Neisseria gonorrhoeae. J Gen Microbiol. 1975 May;88(1):123–131. doi: 10.1099/00221287-88-1-123. [DOI] [PubMed] [Google Scholar]
  213. Stephens D. S., McGee Z. A. Attachment of Neisseria meningitidis to human mucosal surfaces: influence of pili and type of receptor cell. J Infect Dis. 1981 Apr;143(4):525–532. doi: 10.1093/infdis/143.4.525. [DOI] [PubMed] [Google Scholar]
  214. Stephens D. S., McGee Z. A. Attachment of Neisseria meningitidis to human mucosal surfaces: influence of pili and type of receptor cell. J Infect Dis. 1981 Apr;143(4):525–532. doi: 10.1093/infdis/143.4.525. [DOI] [PubMed] [Google Scholar]
  215. Swanson J., Kraus S. J., Gotschlich E. C. Studies on gonococcus infection. I. Pili and zones of adhesion: their relation to gonococcal growth patterns. J Exp Med. 1971 Oct 1;134(4):886–906. doi: 10.1084/jem.134.4.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  216. TAUBER H., RUSSELL H. Enzymes of Neisseria gonorrhoeae and other Neisseria. Proc Soc Exp Biol Med. 1962 Jul;110:440–443. doi: 10.3181/00379727-110-27543. [DOI] [PubMed] [Google Scholar]
  217. THOMAS L. The role of epinephrine in the reactions produced by the endotoxins of gram-negative bacteria. I. Hemorrhagic necrosis produced by epinephrine in the skin of endotoxin-treated rabbits. J Exp Med. 1956 Dec 1;104(6):865–880. doi: 10.1084/jem.104.6.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Tsai C. M., Frasch C. E., Mocca L. F. Five structural classes of major outer membrane proteins in Neisseria meningitidis. J Bacteriol. 1981 Apr;146(1):69–78. doi: 10.1128/jb.146.1.69-78.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Ueda K., Diena B. B., Greenberg L. The chick embryo neutralization test in the assay of meningococcal antibody. 1. Infection of the embryo with Neisseria meningitidis. Bull World Health Organ. 1969;40(2):235–240. [PMC free article] [PubMed] [Google Scholar]
  220. Ueda K., Diena B. B., Sato H., Greenberg L. The chick embryo neutralization test in the assay of meningococcal antibody. 2. Response of the embryo to meningococcal endotoxin and to infection. Bull World Health Organ. 1969;40(2):241–244. [PMC free article] [PubMed] [Google Scholar]
  221. Ueda K., Diena B. B., Wallace R., Sato H., Greenberg L. The chick embryo neutralization test in the assay of meningococcal antibody. 3. Dynamics and specificity of the sero-protection test. Rev Can Biol. 1971 Mar;30(1):1–9. [PubMed] [Google Scholar]
  222. VEITCH F. P., BLANKENSHIP L. C. Carbonic anhydrase in bacteria. Nature. 1963 Jan 5;197:76–77. doi: 10.1038/197076a0. [DOI] [PubMed] [Google Scholar]
  223. Van Epps D. E., Plaut A., Bernier G. M., Williams R. C., Jr IgA paraprotein inhibition of human neutrophil chemotaxis. Reduced activity following treatment with IgA-specific protease from Neisseria gonorrhoeae. Inflammation. 1980 Jun;4(2):137–144. doi: 10.1007/BF00914160. [DOI] [PubMed] [Google Scholar]
  224. Van Snick J. L., Masson P. L., Heremans J. F. The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med. 1974 Oct 1;140(4):1068–1084. doi: 10.1084/jem.140.4.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Wegener W. S., Hebeler B. H., Morse S. A. Cell envelope of Neisseria gonorrhoeae: relationship between autolysis in buffer and the hydrolysis of peptidoglycan. Infect Immun. 1977 Oct;18(1):210–219. doi: 10.1128/iai.18.1.210-219.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Weinberg E. D. Iron and infection. Microbiol Rev. 1978 Mar;42(1):45–66. doi: 10.1128/mr.42.1.45-66.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Winter D. B., Morse S. A. Physiology and metabolism of pathogenic Neisseria: partial characterization of the respiratory chain of Neisseria gonorrhoeae. J Bacteriol. 1975 Aug;123(2):631–636. doi: 10.1128/jb.123.2.631-636.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Wistreich G. A., Baker R. F. The presence of fimbriae (pili) in three species of Neisseria. J Gen Microbiol. 1971 Feb;65(2):167–173. doi: 10.1099/00221287-65-2-167. [DOI] [PubMed] [Google Scholar]
  229. Wolf R. E., Birbara C. A. Meningococcal infections at an army training center. Am J Med. 1968 Feb;44(2):243–255. doi: 10.1016/0002-9343(68)90156-3. [DOI] [PubMed] [Google Scholar]
  230. Wyle F. A., Artenstein M. S., Brandt B. L., Tramont E. C., Kasper D. L., Altieri P. L., Berman S. L., Lowenthal J. P. Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis. 1972 Nov;126(5):514–521. doi: 10.1093/infdis/126.5.514. [DOI] [PubMed] [Google Scholar]
  231. Yancey R. J., Finkelstein R. A. Assmilation of iron by pathogenic Neisseria spp. Infect Immun. 1981 May;32(2):592–599. doi: 10.1128/iai.32.2.592-599.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Yancey R. J., Finkelstein R. A. Siderophore production by pathogenic Neisseria spp. Infect Immun. 1981 May;32(2):600–608. doi: 10.1128/iai.32.2.600-608.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Young L. S., LaForce F. M., Head J. J., Feeley J. C., Bennett J. V. A simultaneous outbreak of meningococcal and influenza infections. N Engl J Med. 1972 Jul 6;287(1):5–9. doi: 10.1056/NEJM197207062870102. [DOI] [PubMed] [Google Scholar]
  234. Yu E. K., DeVoe I. W. L-cysteine oxidase activity in the membrane of Neisseria meningitidis. J Bacteriol. 1981 Jan;145(1):280–287. doi: 10.1128/jb.145.1.280-287.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Yu E. K., DeVoe I. W. Terminal branching of the respiratory electron transport chain in Neisseria meningitidis. J Bacteriol. 1980 Jun;142(3):879–887. doi: 10.1128/jb.142.3.879-887.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  236. Yu E. K., DeVoe I. W. Terminal branching of the respiratory electron transport chain in Neisseria meningitidis. J Bacteriol. 1980 Jun;142(3):879–887. doi: 10.1128/jb.142.3.879-887.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Zollinger W. D., Kasper D. L., Veltri B. J., Artenstein M. S. Isolation and characterization of a native cell wall complex from Neisseria meningitidis. Infect Immun. 1972 Nov;6(5):835–851. doi: 10.1128/iai.6.5.835-851.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Zollinger W. D., Mandrell R. E., Altieri P., Berman S., Lowenthal J., Artenstein M. S. Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. J Infect Dis. 1978 Jun;137(6):728–739. doi: 10.1093/infdis/137.6.728. [DOI] [PubMed] [Google Scholar]
  239. Zollinger W. D., Mandrell R. E. Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins. Infect Immun. 1980 May;28(2):451–458. doi: 10.1128/iai.28.2.451-458.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. de Oliveira Bastos C., Taunay A. de E., da Cruz Tiriba A., Ayroza Galvão P. A. Meningitis meningococica en São Paulo, Brasil. Informe preliminar. Bol Oficina Sanit Panam. 1975 Jul;79(1):54–62. [PubMed] [Google Scholar]
  241. van Deurs B. Observations on the blood-brain barrier in hypertensive rats, with particular reference to phagocytic pericytes. J Ultrastruct Res. 1976 Jul;56(1):65–77. doi: 10.1016/s0022-5320(76)80141-4. [DOI] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES